Macrogen, Inc. (KOSDAQ:038290)
17,270
+280 (1.65%)
At close: Jan 29, 2026
Macrogen Market Cap
Macrogen has a market cap or net worth of 184.2 billion as of January 29, 2026. Its market cap has increased by 12.00% in one year.
Market Cap
184.20B
Enterprise Value
260.98B
Revenue
179.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,270.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has increased from 148.29B to 184.20B, an increase of 24.22%. That is a compound annual growth rate of 0.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 184.20B | 0.71% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JETEMA, | 333.79B |
| HLB Therapeutics | 292.59B |
| Helixmith | 277.20B |
| MedPacto | 226.56B |
| Genexine | 226.49B |
| EASY BIO,Inc. | 222.97B |
| ENCell | 185.73B |
| GeneOne Life Science | 156.77B |